Could a flower extract help stroke patients recover?

NCT ID NCT07003386

Recruiting now Disease control Sponsor: Shanghai Yueyang Integrated Medicine Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether galantamine, a compound from the Lycoris aurea plant, can improve recovery in people who have had an acute ischemic stroke. The trial will involve 66 adults who receive either galantamine injections plus standard care, or standard care alone, for 10 days. Researchers will measure changes in stroke severity, motor function, and brain blood flow to see if the drug helps protect brain cells and improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: galantamine (a plant extract from Lycoris aurea)
What this could lead to: If it works, this could point toward a new treatment to improve recovery and reduce disability after an acute ischemic stroke.
What could go wrong: This is a small, early-phase trial with only 66 participants, so results may not apply to everyone. The drug may not improve outcomes or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE (AIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE (AIS)

Contacts and locations

Locations

Shanghai Yueyang Integrated Medicine Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200080, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.